These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15341359)

  • 1. A multicenter study evaluating the sensitization potential of enamel matrix derivative after treatment of two infrabony defects.
    Froum S; Weinberg M; Novak J; Mailhot J; Mellonig J; Van Dyke T; McClain P; Papapanou PN; Childers G; Ciancio S; Blieden T; Polson A; Greenstein G; Yukna R; Wallace ML; Patters M; Wagener C
    J Periodontol; 2004 Jul; 75(7):1001-8. PubMed ID: 15341359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of wound healing following multiple exposures to enamel matrix protein derivative in the treatment of intrabony periodontal defects.
    Heard RH; Mellonig JT; Brunsvold MA; Lasho DJ; Meffert RM; Cochran DL
    J Periodontol; 2000 Nov; 71(11):1715-21. PubMed ID: 11128919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodontal regeneration with a combination of enamel matrix proteins and autogenous bone grafting.
    Cochran DL; Jones A; Heijl L; Mellonig JT; Schoolfield J; King GN
    J Periodontol; 2003 Sep; 74(9):1269-81. PubMed ID: 14584859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of EDTA root conditioning on the healing of intrabony defects treated with an enamel matrix protein derivative.
    Sculean A; Berakdar M; Willershausen B; Arweiler NB; Becker J; Schwarz F
    J Periodontol; 2006 Jul; 77(7):1167-72. PubMed ID: 16805678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
    Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
    J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study.
    Francetti L; Trombelli L; Lombardo G; Guida L; Cafiero C; Roccuzzo M; Carusi G; Del Fabbro M
    Int J Periodontics Restorative Dent; 2005 Oct; 25(5):461-73. PubMed ID: 16250568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
    Gurinsky BS; Mills MP; Mellonig JT
    J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodontal regeneration with or without limited orthodontics for the treatment of 2- or 3-wall infrabony defects.
    Ogihara S; Wang HL
    J Periodontol; 2010 Dec; 81(12):1734-42. PubMed ID: 20629545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
    Velasquez-Plata D; Scheyer ET; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enamel matrix derivative versus bioactive ceramic filler in the treatment of intrabony defects: 12-month results.
    Leknes KN; Andersen KM; Bøe OE; Skavland RJ; Albandar JM
    J Periodontol; 2009 Feb; 80(2):219-27. PubMed ID: 19186961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periodontal healing after application of enamel matrix derivative in surgical supra/infrabony periodontal defects in rats with streptozotocin-induced diabetes.
    Shirakata Y; Eliezer M; Nemcovsky CE; Weinreb M; Dard M; Sculean A; Bosshardt DD; Moses O
    J Periodontal Res; 2014 Feb; 49(1):93-101. PubMed ID: 23611485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects.
    Tonetti MS; Fourmousis I; Suvan J; Cortellini P; Brägger U; Lang NP;
    J Clin Periodontol; 2004 Dec; 31(12):1092-8. PubMed ID: 15560811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
    Sculean A; Blaes A; Arweiler N; Reich E; Donos N; Brecx M
    J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
    Yilmaz S; Cakar G; Yildirim B; Sculean A
    J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series.
    Yukna RA; Mellonig JT
    J Periodontol; 2000 May; 71(5):752-9. PubMed ID: 10872956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes after treatment of intra-bony defects with an EMD/synthetic bone graft or EMD alone: a multicentre randomized-controlled clinical trial.
    Jepsen S; Topoll H; Rengers H; Heinz B; Teich M; Hoffmann T; Al-Machot E; Meyle J; Jervøe-Storm PM
    J Clin Periodontol; 2008 May; 35(5):420-8. PubMed ID: 18341601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable periodontal healing of 1-wall infrabony defects after application of calcium phosphate cement wall alone or in combination with enamel matrix derivative: a pilot study with canine mandibles.
    Shirakata Y; Yoshimoto T; Goto H; Yonamine Y; Kadomatsu H; Miyamoto M; Nakamura T; Hayashi C; Izumi Y
    J Periodontol; 2007 May; 78(5):889-98. PubMed ID: 17470023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single minimally invasive surgical technique with an enamel matrix derivative to treat multiple adjacent intra-bony defects: clinical outcomes and patient morbidity.
    Cortellini P; Nieri M; Prato GP; Tonetti MS
    J Clin Periodontol; 2008 Jul; 35(7):605-13. PubMed ID: 18476997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of an enamel matrix protein derivative on human teeth following periodontal surgery.
    Sculean A; Windisch P; Keglevich T; Fabi B; Lundgren E; Lyngstadaas PS
    Clin Oral Investig; 2002 Sep; 6(3):183-7. PubMed ID: 12271353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.